British pharma giant AstraZeneca to invest $2.5 billion in new China hub

British pharma giant AstraZeneca to invest .5 billion in new China hub

Outside the Macclesfield factory of AstraZeneca.

Christopher Furlong | Getty Images News | Getty Images

British pharmaceutical giant AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing.

The new hub is expected to take AstraZeneca’s Beijing workforce to around 1,700 employees.

Don’t miss AstraZeneca’s CEO Pascal Soriot interview live on CNBC International at 11:30 a.m. London time / 7:30 a.m. ET.

This breaking news story is being updated.

Source

Health

Jim Cramer has faith in Danaher’s turnaround as life sciences comes back to life

December 2, 2025

Life sciences stocks are seeing a resurgence — and that’s good news for Danaher . Connecting the dots to better times ahead for the struggling portfolio name, Jim Cramer thinks the industry turnaround is best illustrated by looking at Agilent Technologies ‘ recovery from a post-Covid rut. Shares are up around 50% from their April […]

Health

‘Advice was so good,’ says CEO who used ChatGPT to pitch new ideas to AI versions of business icons

December 2, 2025

Joanna Stober, Midi Health CEO and co-founder, has never had an opportunity to run her business plans past legendary venture capital investor John Doerr, chairman at Kleiner Perkins. But that didn’t stop her from tapping Doerr, in an AI version, for advice on growing her startup, a virtual clinic offering midlife health care for women. […]

Health

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

December 1, 2025

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the […]